...
首页> 外文期刊>Comparative biochemistry and physiology. Toxicology & pharmacology: CBP >Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3 ' R/S isomers of astaxanthin fatty acyl diesters
【24h】

Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3 ' R/S isomers of astaxanthin fatty acyl diesters

机译:给定剂量的虾青素脂肪酰基二酯的光学3和3'R / S异构体混合物的男性,未酯化虾青素几何E / Z和光学R / S异构体的血浆

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Appearance, pharmacokinetics and distribution of astaxanthin all-E-, 9Z- and 13Z-geomettical and (3R,3R)-, (3R,3S)- and (3S,3S)-optical isomers in plasma fractions were studied in three middle-aged male volunteers (41-50 years) after ingestion of a single meal containing first a 10 mg dose equivalent of astaxanthin from astaxanthin diesters, followed by a dose of 100 mg astaxanthin equivalents after 4 weeks. Direct resolution of geometrical isomers and optical isomers of astaxanthin dicamphanates by HPLC after saponification showed that the astaxanthin consisted of 95.2% all-E-, 1.2% 9Z- and 3.6% 13Z-astaxanthin, of (3R,3R)-, (3R,3S; meso)- and (3S,3S)-astaxanthin in a 31:49:20 ratio. The plasma astaxanthin concentration-time curves were measured during 76 h. Astaxanthin esters were not detected in plasma. Maximum levels of astaxanthin (C-max=0.28+/-0.1 mg/1) were reached 11.5 h after administration and the plasma astaxanthin elimination half-life was 52+/-40 h. The C-max at the low dose was 0.08 mg/l and showed that, the dose response was non-linear. The (3R,P)-astaxanthin optical isomer accumulated selectively in plasma compared to the (3R,35)- and (3S,3S)-isomers, and comprised 54% of total astaxanthin in the blood and only 31% of total astaxanthin in the administered dose. The astaxanthin Z-isomers were absorbed selectively into plasma and comprised similar to32% of total astaxanthin 6-7.5 h postprandially. The proportion of all-E-astaxanthin was significantly higher in the very low density lipoproteins and chylomicrons (VLDL/CM) plasma lipoprotein fraction than in the high density lipoproteins (HDL) and low density lipoproteins (LDL) fractions (P<0.05). The results indicate that a selective process increase the relative proportion of astaxanthin Z-isomers compared to the all-E-astaxanthin before uptake in blood and that the astaxanthin esters are hydrolyzed selectively during absorption. (C) 2004 Elsevier Inc. All rights reserved.
机译:研究了三个中间部分的虾青素全-E-,9Z-和13Z-基因型以及(3R,3R)-,(3R,3S)-和(3S,3S)-光学异构体的外观,药代动力学和分布进食单餐后,首先包含来自虾青素二酯的10毫克剂量当量的虾青素,然后在4周后服用100毫克虾青素当量的老年男性志愿者(41-50岁)。皂化后通过HPLC直接解析虾青素二樟脑酸酯的几何异构体和旋光异构体,表明虾青素由95.2%的all-E-,1.2%的9Z-和3.6%的13Z​​-黄素。 3S; meso)-和(3S,3S)-astaxanthin的比例为31:49:20。在76小时内测量血浆虾青素浓度-时间曲线。在血浆中未检测到虾青素酯。给药后11.5小时达到虾青素的最大水平(C-max = 0.28 +/- 0.1 mg / 1),血浆虾青素消除半衰期为52 +/- 40 h。低剂量时的C-max为0.08 mg / l,表明剂量响应是非线性的。与(3R,35)-和(3S,3S)-异构体相比,(3R,P)-虾青素光学异构体在血浆中选择性积累,占血液中虾青素总量的54%,而仅占虾青素总量的31%给药剂量。餐后6-7.5h,虾青素Z-异构体被选择性吸收到血浆中,占虾青素总量的32%。在极低密度脂蛋白和乳糜微粒(VLDL / CM)血浆脂蛋白组分中,全E-天黄质的比例明显高于在高密度脂蛋白(HDL)和低密度脂蛋白(LDL)中的组分(P <0.05)。结果表明,选择性过程增加了虾青素Z异构体相对于全E虾青素在血液中的相对比例,并且在吸收过程中虾青素酯被选择性水解。 (C)2004 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号